Name: Globus Medical Retained Earnings (Accumulated Deficit) 2010-2025 | GMED
Creator: MACROTRENDS
License: https://creativecommons.org/licenses/by/4.0/

Warning: Undefined variable $sector_url in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1234

Warning: Undefined variable $base_url in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1245

Warning: Undefined variable $industry_url in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1247

Warning: Undefined variable $base_url in /var/www/html/macrotrends/public_html/production/stock_metadata.php on line 1261
Globus Medical Retained Earnings (Accumulated Deficit) 2010-2025 | GMED | MacroTrends

Globus Medical Retained Earnings (Accumulated Deficit) 2010-2025 | GMED

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Globus Medical retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $1.036B, a 1.02% decline year-over-year.

Globus Medical retained earnings (accumulated deficit) for 2024 were $1.153B, a 1.37% increase from 2023.
Globus Medical retained earnings (accumulated deficit) for 2023 were $1.137B, a 8.28% decline from 2022.
Globus Medical retained earnings (accumulated deficit) for 2022 were $1.24B, a 3.82% increase from 2021.

Globus Medical Retained Earnings (Accumulated Deficit) 2010-2025 | GMED

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Globus Medical retained earnings (accumulated deficit) for 2024 were $1.153B, a 1.37% increase from 2023.
Globus Medical retained earnings (accumulated deficit) for 2023 were $1.137B, a 8.28% decline from 2022.
Globus Medical retained earnings (accumulated deficit) for 2022 were $1.24B, a 3.82% increase from 2021.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$171.9B
Thermo Fisher Scientific (TMO)	$161.4B
Alcon (ALC)	$45.6B
Edwards Lifesciences (EW)	$42B
IDEXX Laboratories (IDXX)	$33.3B
DexCom (DXCM)	$26.9B
IQVIA Holdings (IQV)	$25.4B
STERIS (STE)	$21.8B
Mettler-Toledo (MTD)	$20.9B
Waters (WAT)	$19.1B
SONOVA HOLDING (SONVY)	$17.3B
Fresenius Medical Care AG KGaA (FMS)	$13.9B
Hologic (HOLX)	$12.9B
Sysmex ADR (SSMXY)	$11.8B
Penumbra (PEN)	$10.7B
Masimo (MASI)	$8.2B
Teleflex (TFX)	$6B
Glaukos (GKOS)	$5.2B
Integer Holdings (ITGR)	$4.1B
TransMedics (TMDX)	$3B
PROCEPT BioRobotics (PRCT)	$2.9B
Veracyte (VCYT)	$2.4B
Nihon Kohden (NHNKY)	$2.1B
LivaNova (LIVN)	$1.9B
Elekta AB (EKTAY)	$1.9B
Alphatec Holdings (ATEC)	$1.5B
Integra LifeSciences Holdings (IART)	$1.2B
Pulse Biosciences (PLSE)	$1.2B
Tandem Diabetes Care (TNDM)	$1.1B
Paragon 28 (FNA)	$1.1B